title: Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice.
authors.forename: Usha
authors.initials: U
authors.lastname: Stiefel
authors.forename: Jaana
authors.initials: J
authors.lastname: Harmoinen
authors.forename: Pertti
authors.initials: P
authors.lastname: Koski
authors.forename: Susanna
authors.initials: S
authors.lastname: Kääriäinen
authors.forename: Nina
authors.initials: N
authors.lastname: Wickstrand
authors.forename: Kai
authors.initials: K
authors.lastname: Lindevall
authors.forename: Nicole J
authors.initials: NJ
authors.lastname: Pultz
authors.forename: Robert A
authors.initials: RA
authors.lastname: Bonomo
authors.forename: Marion S
authors.initials: MS
authors.lastname: Helfand
authors.forename: Curtis J
authors.initials: CJ
authors.lastname: Donskey
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D004357:Drug Synergism; D051379:Mice; D010397:Penicillanic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D010878:Piperacillin / Q000494:pharmacology*; D000078142:Tazobactam; D018440:beta-Lactam Resistance / Q000187:drug effects*; D001618:beta-Lactamases / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D010397:Penicillanic Acid; D001618:beta-Lactamases; D000078142:Tazobactam; D010878:Piperacillin